Report on how AI is redefining market landscape - The global effervescent tablet market size is estimated to grow by USD 4.80 ...

This strategy enables Pfizer to maintain a strong foothold in the generic drug market while also protecting its revenue ...

Diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant) and inactivated poliovirus vaccine combined Pediarix (GlaxoSmithKline) 24 hr Manufacturer Diphtheria and ...

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary ... the company increased the installed capacity of Tablets and Capsules from 6750 million nos to 6950 million nos. They increased the ...

Aurinia Pharma and partner Otsuka have secured approval ... becoming the first oral alternative to GSK's injectable anti-BLyS/BAFF antibody Benlysta (belimumab) for the treatment of active LN ...

Wellnex Life Ltd (ASX:WNX) is supplying the liquid softgel painkillers being sold by $60 billion UK giant Haleon under its ...

Reddy's Laboratories is among India’s leading pharmaceutical companies ... acquired the US penicillin facility and products of GlaxoSmithKline. 2016 was important for the company as it ventured ...

GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 ...

GSK, a UK-based biopharma, reported strong 2024 results, with a promising shift toward specialty medicines. Read why I ...

In October, when GSK agreed to a $2.2 billion settlement to resolve approximately 80,000 lawsuits | With a $2.2 billion ...

The long-running HIV market rivalry between Gilead Sciences and GSK is about to turn a new page this year as Gilead looks to ...